Chapter 1. Market Scope and Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Genetic Testing Market, by Type
1.4.2 Europe Genetic Testing Market, by Technology
1.4.3 Europe Genetic Testing Market, by Application
1.4.4 Europe Genetic Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Genetic Testing Market by Type
3.1 Europe Predictive and Presymptomatic Testing Market by Country
3.2 Europe Carrier Testing Market by Country
3.3 Europe Prenatal and Newborn Testing Market by Country
3.4 Europe Diagnostic Testing Market by Country
3.5 Europe Pharmacogenomic Testing Market by Country
3.6 Europe Other Types Genetic Testing Market by Country
Chapter 4. Europe Genetic Testing Market by Technology
4.1 Europe Cytogenetic Testing Market by Country
4.2 Europe Biochemical Testing Market by Country
4.3 Europe Molecular Testing Market by Country
Chapter 5. Europe Genetic Testing Market by Application
5.1 Europe Cancer Diagnosis Market by Country
5.2 Europe Genetic Disease Diagnosis Market by Country
5.3 Europe Cardiovascular Disease Diagnosis Market by Country
5.4 Europe Other Applications Market by Country
Chapter 6. Europe Genetic Testing Market by Country
6.1 Germany Genetic Testing Market
6.1.1 Germany Genetic Testing Market by Type
6.1.2 Germany Genetic Testing Market by Technology
6.1.3 Germany Genetic Testing Market by Application
6.2 UK Genetic Testing Market
6.2.1 UK Genetic Testing Market by Type
6.2.2 UK Genetic Testing Market by Technology
6.2.3 UK Genetic Testing Market by Application
6.3 France Genetic Testing Market
6.3.1 France Genetic Testing Market by Type
6.3.2 France Genetic Testing Market by Technology
6.3.3 France Genetic Testing Market by Application
6.4 Russia Genetic Testing Market
6.4.1 Russia Genetic Testing Market by Type
6.4.2 Russia Genetic Testing Market by Technology
6.4.3 Russia Genetic Testing Market by Application
6.5 Spain Genetic Testing Market
6.5.1 Spain Genetic Testing Market by Type
6.5.2 Spain Genetic Testing Market by Technology
6.5.3 Spain Genetic Testing Market by Application
6.6 Italy Genetic Testing Market
6.6.1 Italy Genetic Testing Market by Type
6.6.2 Italy Genetic Testing Market by Technology
6.6.3 Italy Genetic Testing Market by Application
6.7 Rest of Europe Genetic Testing Market
6.7.1 Rest of Europe Genetic Testing Market by Type
6.7.2 Rest of Europe Genetic Testing Market by Technology
6.7.3 Rest of Europe Genetic Testing Market by Application
Chapter 7. Company Profiles
7.1 Myriad Genetics, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Research and Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches:
7.1.5.2 Collaborations, Partnerships and agreements:
7.2 Empire Genomics LLC
7.2.1 Company Overview
7.3 Bio-Rad laboratories, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Collaborations, partnerships and agreements:
7.3.4.2 Product launches:
7.3.4.3 Acquisition and mergers:
7.3.5 Research and Development Expenses
7.4 Novartis AG
7.4.1 Company Overview
7.4.1 Financial Analysis
7.4.2 Segmental and Regional Analysis
7.4.3 Research and Development Expense
7.4.4 Recent strategies and developments:
7.4.4.1 Collaborations, partnerships and agreements:
7.5 Agilent Technologies, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research and Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Product launches:
7.5.5.2 Expansions:
7.6 Thermo Fischer Scientific, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research and Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Collaborations, partnerships and agreements:
7.6.5.2 Acquisition and mergers:
7.7 Qiagen N.V.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research and Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product launches:
7.7.5.2 Collaborations, partnerships and agreements:
7.8 Illumina, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research and Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.8.5.2 Product launches:
7.9 Danaher Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research and Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and mergers:
7.1 Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research and Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Collaborations, partnerships and agreements:
7.10.5.2 Product launches:
Unique Offerings 
